Ategrity Specialty Insurance
Underwrites E&S coverage for U.S. small-business and middle-market commercial risks.
Something off on this page? Send us feedback.
Profile
Underwrites excess-and-surplus insurance for small and medium-sized U.S. businesses through wholesale brokers and surplus-lines agents. Coverage spans casualty, commercial property, management liability, professional liability, allied healthcare, and architects-and-engineers E&O, with a single operating segment built around technology-enabled underwriting.
Underwrites excess-and-surplus property-and-casualty coverage for small and medium-sized U.S. businesses. Product lines include general liability, commercial property, management liability, miscellaneous professional liability, allied healthcare, and architects-and-engineers E&O, with casualty and property forming the core underwriting mix.
Sells exclusively through licensed surplus-lines brokers and wholesale agents, using brokerage and small-business channels. The platform emphasizes productionized underwriting: micro-segmentation, centralized underwriting governance, data analytics, and automated workflows for high-volume submissions.
Operations are concentrated in the United States and reported as one E&S insurance segment. Distribution relationships, underwriting discipline, claims handling, financial-strength ratings, and the regulatory treatment of non-admitted insurance shape the business.
Company facts
Key statistics
Year to date +31.6% · Average volume (30d) 72.3K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | Barclays | Reiterate | Overweight | $26 | $28 | |
| Feb 26, 2026 | Citigroup | Downgrade | Buy | Neutral | ||
| Feb 20, 2026 | Barclays | Reiterate | Overweight | $25 | $26 | |
| Jan 13, 2026 | Wells Fargo | Reiterate | Overweight | $23 | $25 | |
| Jan 8, 2026 | Barclays | Reiterate | Overweight | $25 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026Q2 FY26 | $0.53 | $0.67 | +27.1% | $124.4M | $206.8M | +66.3% | −3.21% |
| Apr 29, 2026Q1 FY26 | $0.40 | $0.51 | +27.5% | $117.9M | $142.9M | +21.3% | −7.36% |
| Feb 19, 2026Q4 FY25 | $0.35 | $0.51 | +45.7% | $106.1M | $154.0M | +45.1% | +23.60% |
| Oct 22, 2025Q3 FY25 | $0.33 | $0.46 | +39.4% | $99.0M | $116.1M | +17.2% | −0.42% |
Financial highlights
| 8 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $83.1M | $101.8M | $116.1M | $123.3M | $129.0M | $148.5M | |
| Gross profit | $21.7M | $35.3M | $59.9M | $95.3M | $67.1M | $82.0M | |
| Operating income | $10.7M | $22.3M | $29.7M | $33.2M | $34.2M | $46.4M | |
| Net income | $8.5M | $17.6M | $22.7M | $25.3M | $25.5M | $33.5M | |
| Diluted EPS | $0.17 | $0.40 | $0.45 | $0.51 | $0.51 | $0.67 | |
| Gross margin | 26.1% | 34.7% | 51.6% | 77.3% | 52.0% | 55.2% | |
| Operating margin | 12.9% | 21.9% | 25.6% | 26.9% | 26.5% | 31.3% |
Fiscal years (4-quarter sums)FY25 $424.3M
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $644.6M · Total debt $1.8M · Total assets $1.40B · Shareholders' equity $664.4M
Dividends
No dividends on record.
Ownership
Shares outstanding 48.03M · Float 7.59M · 15.8% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Stuart J. Zimmer · director, 10 percent owner: | 38.54M | 80.23% | Form 4 | Oct 1, 2025 |
| Nuveen, LLC | 712.1K | 1.48% | 13F | Apr 30, 2026 |
| T. Rowe Price Investment Management, Inc. | 569.7K | 1.19% | 13F | May 15, 2026 |
| BlackRock, Inc. | 567.0K | 1.18% | 13F | May 13, 2026 |
| Cannell Capital LLC | 486.5K | 1.01% | 13F | May 15, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 4, 2026 | Chris Schenk | officer: See Remarks | +2,500 | $19.99 |
| Oct 27, 2025 | Justin G. Cohen | director, officer: Chief Executive Officer | +5,200 | $19.41 |
| Sep 29, 2025 | Stuart J. Zimmer | director, 10 percent owner: | +6,130 | $19.37 |
| Sep 30, 2025 | Stuart J. Zimmer | director, 10 percent owner: | +5,000 | $19.47 |
| Sep 25, 2025 | Stuart J. Zimmer | director, 10 percent owner: | +4,179 | $19.45 |
Peers
- Kinsale Capital Group
Pure-play E&S insurer overlapping in casualty, property, and SMB risks
- W. R. Berkley
Large commercial P&C group with multiple U.S. E&S platforms
- Markel Group
Global specialty insurer with U.S. wholesale E&S overlap
- RLI
Specialty P&C writer active in E&S casualty and property
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Ategrity Specialty Insurance | $26.59 | +0.19% | $1.28B | 12.4 | 11.6 | 2.5 | +103.2% |
| Kinsale Capital Group | $385.00 | +1.13% | $8.67B | 15.4 | 18.1 | 4.3 | −3.7% |
| W. R. Berkley | $70.65 | +3.20% | $25.48B | 14.1 | 14.5 | 1.4 | +1.2% |
| Markel Group | $1,818.69 | −0.07% | $22.53B | 10.0 | 15.8 | 1.3 | +17.6% |
| RLI | $64.31 | +0.03% | $5.90B | 13.5 | 23.8 | 3.0 | +16.0% |
| Median | 13.8 | 17.0 | 2.2 | +8.6% |






